{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-008387","form_type":"8-K","ticker":"GTBP","cik":"0000109657","company_name":"GT Biopharma, Inc.","filed_at":"2025-02-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.925044+00:00","generated_at":"2026-05-26T03:13:15.179292+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"GT Biopharma induces exercise of 302K warrants at $2.27, raises ~$0.7M; issues new warrants for 604K shares","bullets":["Entered inducement letters with holders of 302,069 existing warrants to exercise at reduced price of $2.27/share, raising ~$0.7M gross proceeds.","In exchange, issued Series A (5-year term) and Series B (18-month term) inducement warrants at $2.02 exercise price for up to 604,138 shares total.","New warrants are unregistered; company to file resale registration statement within 30 days.","Net proceeds to be used for working capital and general corporate purposes."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-008387","json":"https://secwatch.observer/filing/0001493152-25-008387.json","markdown":"https://secwatch.observer/filing/0001493152-25-008387.md","text":"https://secwatch.observer/filing/0001493152-25-008387.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/109657/000149315225008387/0001493152-25-008387-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/109657/000149315225008387/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T03:13:15.179292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}